DELPHI GENETICS has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), Brazil and Canada. Its main competitors in its focus markets biotechnology and foods and drinks are AMYLOGENE HB, EVIAGENICS S A and GENEWIZ INC SZ.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | Chile | 2 | |
#5 | China | 2 | |
#6 | Japan | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Argentina | 1 | |
#9 | Australia | 1 | |
#10 | India | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Fermentation | |
#3 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Szpirer Cedric | 9 |
#2 | Michel Benjamin | 7 |
#3 | Cavrenne Jonathan | 7 |
#4 | Szpirer Cédric | 5 |
#5 | Jonathan Cavrenne | 3 |
#6 | Benjamin Michel | 3 |
#7 | Cédric Szpirer | 2 |
#8 | Cedric Szpirer | 2 |
#9 | Cdric Szpirer | 1 |
Publication | Filing date | Title |
---|---|---|
AU2015293825A1 | Improved host cell for producing proteins | |
CN103797113A | Genetically modified phage and use thereof | |
EP2543720A1 | Genetically modified phage and use thereof |